Impact of phosphorylated insulin-like growth factor-1 receptor on the outcome of breast cancer patients and the prognostic value of its alteration during neoadjuvant chemotherapy | |
Li, Liang; Liu, Shuchen; Liu, Liyuan; Ma, Zhongbing; Feng, Man; Ye, Chunmiao; Zhou, Wenzhong; Wang, Yongjiu; Liu, Lu; Wang, Fei | |
刊名 | EXPERIMENTAL AND THERAPEUTIC MEDICINE |
2018 | |
卷号 | 16期号:4页码:2949-2959 |
关键词 | insulin-like growth factor-1 receptor breast cancer prognostic value neoadjuvant chemotherapy clinical characteristics pathological characteristics |
DOI | 10.3892/etm.2018.6584 |
URL标识 | 查看原文 |
公开日期 | [db:dc_date_available] |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4569957 |
专题 | 山东大学 |
作者单位 | 1.[Li, Liang 2.Liu, Shuchen 3.Liu, Liyuan 4.Ma, Zhongbing 5.Ye, Chunmiao 6.Zhou, Wenzhong 7.Wang, Yongjiu 8.Liu, Lu 9.Wang, Fei 10.Yu, Lixiang |
推荐引用方式 GB/T 7714 | Li, Liang,Liu, Shuchen,Liu, Liyuan,et al. Impact of phosphorylated insulin-like growth factor-1 receptor on the outcome of breast cancer patients and the prognostic value of its alteration during neoadjuvant chemotherapy[J]. EXPERIMENTAL AND THERAPEUTIC MEDICINE,2018,16(4):2949-2959. |
APA | Li, Liang.,Liu, Shuchen.,Liu, Liyuan.,Ma, Zhongbing.,Feng, Man.,...&Y 更多.(2018).Impact of phosphorylated insulin-like growth factor-1 receptor on the outcome of breast cancer patients and the prognostic value of its alteration during neoadjuvant chemotherapy.EXPERIMENTAL AND THERAPEUTIC MEDICINE,16(4),2949-2959. |
MLA | Li, Liang,et al."Impact of phosphorylated insulin-like growth factor-1 receptor on the outcome of breast cancer patients and the prognostic value of its alteration during neoadjuvant chemotherapy".EXPERIMENTAL AND THERAPEUTIC MEDICINE 16.4(2018):2949-2959. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论